current standard treatment options for pstage iii gastric or g/gej cancer
Published 1 year ago • 105 plays • Length 0:41Download video MP4
Download video MP3
Similar videos
-
1:11
attraction-5: nivo chemo as postoperative adju treatment for pathological stage iii g/gej cancer
-
35:36
personalized treatment of advanced her2-negative gastric or gastroesophageal junction cancer
-
0:33
subgroup analysis of attraction-5: benefit of nivolumab in g/gej advanced pd-l1-positive tumors
-
22:57
current treatments, limitations and new directions for gastric and oesophageal cancer
-
3:01
genomic landscape of late-stage gastric cancer treated with pembrolizumab
-
5:00
surgical advances in in gastric and gej cancer
-
1:35:13
catalysts for change in gastric & gej cancer
-
30:31
gastroesophageal cancer: current positioning of immunotherapy
-
44:44
gastric cancer 2022
-
0:54
perioperative pembrolizumab for stomach cancer treatment
-
25:49
gastric cancer: causes, standard therapy, and new breakthrough treatments
-
20:21
check-point inhibitors in esophageal and gastric cancer: when and for whom?
-
56:48
immunotherapy for gastroesophageal cancer
-
3:09
medical oncology treatment options for stomach cancer
-
17:37
what is the most optimum perioperative treatment in esophageal cancer
-
5:06
treating unresectable or metastatic gastric/gej cancers
-
1:01:38
new options for gastrointestinal cancer therapies
-
30:59
algorithms for management of locally-advanced and metastatic gastric & ge junction adenocarcinomas
-
1:59:52
2012 focus on gastrointestinal cancers conference - esophageal & stomach cancer workshop